Activity of andrographolide and its derivatives on HPV16 pseudovirus infection and viral oncogene expression in cervical carcinoma cells

Nutrition and Cancer

Volumn 67, Issue 4, 2015, Pages 687-696

  Ekalaksananan, Tipaya ^a   Sookmai, Waree ^a   Fangkham, Supada ^a   Pientong, Chamsai ^a   Aromdee, Chantana ^b   Seubsasana, Supawadee ^c   Kongyingyoes, Bunkerd ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGRAPHOLIDE; PROTEIN P53; 14-DEOXY-11,12-DIDEHYDROANDROGRAPHOLIDE; ANTIVIRUS AGENT; DITERPENE; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; MESSENGER RNA; ONCOPROTEIN; REPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE M PHASE; CELL VIABILITY; DOSE RESPONSE; DRUG EFFECT; EMBRYO; EXPRESSION VECTOR; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; UTERINE CERVIX CARCINOMA; VIRUS ONCOGENE; CELL CYCLE; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ANTIVIRAL AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84929129260     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1019630     Document Type: Article

References (34)

1. Chao WW and Lin BF: Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med 5, 17, 2010.
2. Shi MD, Lin HH, Chiang TA, Tsai LY, Tsai SM, et al.: Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression. Chem Biol Interact 180, 344-352, 2009.
3. Shen YC, Chen CF, and Chiou WF: Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135, 399-406, 2002.
4. Shen YC, Chen CF, and Chiou WF: Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med 66, 314-317, 2000.
5. Amroyan E, Gabrielian E, Panossian A, Wikman G, and Wagner H: Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 6, 27-31, 1999.
6. Trivedi NP, Rawal UM, and Patel BP: Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury. Integr Cancer Ther 6, 271-280, 2007.
7. Chang RS, Ding L, Chen GQ, Pan QC, Zhao ZL, et al.: Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med 197, 59-66, 1991.
8. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, et al.: A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14, 333-338, 2000.
9. Matsuda T, Kuroyanagi M, Sugiyama S, Umehara K, Ueno A, et al.: Cell differentiation-inducing diterpenes from Andrographis paniculata Nees. Chem Pharm Bull (Tokyo) 42, 1216-1225, 1994.
10. Kumar RA, Sridevi K, Kumar NV, Nanduri S, and Rajagopal S: Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 92, 291-295, 2004.
11. Shi MD, Lin HH, Lee YC, Chao JK, Lin RA, et al.: Inhibition of cellcycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem Biol Interact 174, 201-210, 2008.
12. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al.: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527, 2003.
13. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342-350, 2002.
14. Howie HL, Katzenellenbogen RA, and Galloway DA: Papillomavirus E6 proteins. Virology 384, 324-334, 2009.
15. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136, 1990.
16. Scheffner M, Huibregtse JM, Vierstra RD, and Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505, 1993.
17. Stanley MA, Pett MR, and Coleman N: HPV: from infection to cancer. Biochem Soc Trans 35, 1456-1460, 2007.
18. Woodman CB, Collins SI, and Young LS: The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7, 11-22, 2007.
19. Aromdee C, Suebsasana S, Ekalaksananan T, Pientong C, and Thongchai S: Stage of action of naturally occurring andrographolides and their semisynthetic analogues against herpes simplex virus type 1 in vitro. Planta Med 77, 915-921, 2011.
20. Pientong C, Wongwarissara P, Ekalaksananan T, Swangphon P, Kleebkaow P, et al.: Association of human papillomavirus type 16 long control region mutation and cervical cancer. Virol J 10, 30, 2013.
21. Buck CB, Thompson CD, Pang YY, Lowy DR, and Schiller JT: Maturation of papillomavirus capsids. J Virol 79, 2839-2846, 2005.
22. Kim HJ, Kim SY, Lim SJ, Kim JY, and Lee SJ: One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr Purif 70, 68-74, 2010.
23. Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, et al.: Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321, 205-216, 2004.
24. Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, et al.: The antipapillomavirus activity of human and bovine lactoferricin. Antiviral Res 75, 258-265, 2007.
25. Wiart C, Kumar K, Yusof MY, Hamimah H, Fauzi ZM, et al.: Antiviral properties of ent-labdene diterpenes of Andrographis paniculata nees, inhibitors of herpes simplex virus type 1. Phytother Res 19, 1069-1070, 2005.
26. Drobni P, Naslund J, and Evander M: Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral Res 64, 63-68, 2004.
27. Zhao F, He EQ, Wang L, and Liu K: Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level. J Asian Nat Prod Res 10, 467-473, 2008.
28. Sukardiman H, Widyawaruyanti A, Sismindari, and Zaini NC: Apoptosis inducing effect of andrographolide on TD-47 human breast cancer cell line. Afr J Tradit Complement Altern Med 4, 345-351, 2007.
29. Cheung HY, Cheung SH, Li J, Cheung CS, Lai WP, et al.: Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med 71, 1106-1111, 2005.
30. Yan J, Chen Y, He C, Yang ZZ, Lu C, et al.: Andrographolide induces cell cycle arrest and apoptosis in human rheumatoid arthritis fibroblastlike synoviocytes. Cell Biol Toxicol 28, 47-56, 2012.
31. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, et al.: A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356, 1995.
32. Di Leonardo A, Khan SH, Linke SP, Greco V, Seidita G, et al.: DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Research 57, 1013-1019, 1997.
33. Lanni JS and Jacks T: Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Molecular and Cellular Biology 18, 1055-1064, 1998.
34. Li J, Cheung HY, Zhang Z, Chan GK, and Fong WF: Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Eur J Pharmacol 568, 31-44, 2007.